Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Urban, C; Benesch, M; Sovinz, P; Schwinger, W; Lackner, H.
Fatal Evans' syndrome after matched unrelated donor transplantation for hyper-IgM syndrome.
EUR J HAEMATOL. 2004; 72(6): 444-447.
Doi: 10.1111/j.1600-0609.2004.00256.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
-
Benesch Martin
-
Urban Ernst-Christian
- Co-Autor*innen der Med Uni Graz
-
Lackner Herwig
-
Ritter-Sovinz Petra
-
Schwinger Wolfgang
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- A 3 and 1/2-yr-old boy underwent matched unrelated stem cell transplantation (SCT) for hyper-IgM syndrome. He developed acute and chronic skin graft-vs.-host disease (GVHD). Ten months following SCT he presented with severe hemolytic anemia and thrombocytopenia (Evans' syndrome). Treatment included high-dose steroids, intravenous immunoglobulins, cyclosporine, mycophenolate mofetil, chemotherapeutic agents (cyclophosphamide, vincristine, VP-16), immunoadsorption, and anti-CD20 and anti-CD52 monoclonal antibodies without response. The patient died 16 months after SCT.
- Find related publications in this database (using NLM MeSH Indexing)
-
Anemia, Hemolytic, Autoimmune - drug therapy
-
Blood Donors - drug therapy
-
Fatal Outcome - drug therapy
-
Graft vs Host Disease - etiology
-
Hematopoietic Stem Cell Transplantation - adverse effects
-
Humans - adverse effects
-
Immunoglobulin M - adverse effects
-
Immunologic Deficiency Syndromes - complications
-
Immunosuppressive Agents - therapeutic use
-
Infant - therapeutic use
-
Male - therapeutic use
-
Skin Diseases - etiology
-
Syndrome - etiology
-
Thrombocytopenia - drug therapy
-
Treatment Failure - drug therapy
- Find related publications in this database (Keywords)
-
Evans' syndrome
-
hyper-IgM syndrome
-
stem cell transplantation